Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals by Salazar, Martín R. et al.
Nutrition, Metabolism & Cardiovascular Diseases (2017) 27, 366e373Available online at www.sciencedirect.com
Nutrition, Metabolism & Cardiovascular Diseases
j ournal homepage: www.e lsev ier .com/ locate /nmcdComparison of two surrogate estimates of insulin resistance to
predict cardiovascular disease in apparently healthy individuals
M.R. Salazar a,b,*, H.A. Carbajal b, W.G. Espeche a,b, M. Aizpurúa c, C.A. Dulbecco a,b,
G.M. Reaven d
aHospital Universitario General San Martín, La Plata, Buenos Aires, Argentina
b Facultad de Ciencias Médicas, UNLP, Argentina
cHospital Municipal de Rauch, Buenos Aires, Argentina
d Stanford University School of Medicine, Stanford, CA, USAReceived 17 July 2016; received in revised form 5 December 2016; accepted 12 December 2016
Available online 24 December 2016KEYWORDS
Insulin resistance;
Cardiovascular
disease;
TG/HDL-C ratio;
TG  G index;
Metabolic syndrome* Corresponding author. 14 n 320,
Argentina. Fax: þ54 221 4129164.
E-mail address: salazarlandea@gmail
http://dx.doi.org/10.1016/j.numecd.2016.12.002
0939-4753/ª 2016 The Italian Society of Diabet
Medicine and Surgery, Federico II University. PAbstract Background and aims: Insulin resistance is associated with a cluster of abnormalities
that increase cardiovascular disease (CVD). Several indices have been proposed to identify indi-
viduals who are insulin resistant, and thereby at increased CVD risk. The aim of this study was to
compare the abilities of 3 indices to accomplish that goal: 1) plasma triglyceride  glucose index
(TG  G); 2) plasma triglyceride/high-density lipoprotein cholesterol ratio (TG/HDL-C); and 3)
Metabolic Syndrome (MetS).
Methods and results: In a population sample of 723 individuals (486 women and 237 men,
50  16 and 51  16 years old, respectively), baseline demographic and metabolic variables
known to increase CVD risk and incident CVD were compared among individuals defined as high
vs. low risk by: TG  G; TG/HDL-C; or MetS. CVD risk profiles appeared comparable in high risk
subjects, irrespective of criteria. Crude incidence of CVD events was increased in high risk sub-
jects: 12.2 vs. 5.3% subjects/10 years, p Z 0.005 defined by TG/HDL-C; 13.4 vs. 5.3% subjects/10
years, pZ 0.002 defined by TG  G; and 13.4% vs. 4.5% of subjects/10 years, p < 0.001 in subjects
with the MetS. The area under the ROC curves to predict CVD were similar, 0.66 vs. 0.67 for TG/
HDL-C and TG  G, respectively. However, when adjusted by age, sex and multiple covariates,
hazard ratios for incident CVD were significantly increased in high risk patients classified by
either TG/HDL-C ratio (2.18, p Z 0.021) or MetS (1.93, p Z 0.037), but not by TG  G index
(1.72, p Z 0.087).
Conclusion: Although the 3 indices identify CVD risk comparably, the TG  G index seems some-
what less effective at predicting CVD.
ª 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the
Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Feder-
ico II University. Published by Elsevier B.V. All rights reserved.Introduction
Insulin-mediated glucose disposal varies more than six-
fold in volunteers with a normal medical history, physical
examination, routine clinical laboratory tests, as well as aLa Plata 1900, Buenos Aires,
.com (M.R. Salazar).
ology, the Italian Society for the Study of A
ublished by Elsevier B.V. All rights reservenormal oral glucose tolerance test [1]. Approximately one-
quarter to one-third of the most insulin resistant segment
of such a population is at significantly greater risk [2e5] of
a number of metabolic abnormalities known to increase
risk of cardiovascular disease (CVD). Although it seems
clinically beneficial to identify these high risk individuals
in order to attempt interventions that might prevent
manifest disease, how best to accomplish this goal is not
self-evident.therosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical
d.
Estimates of insulin resistance and cardiovascular disease 367The plasma insulin concentration in response to a 75 g
oral glucose challenge in apparently normal individuals is
the surrogate estimate of insulin resistance most closely
correlated to direct measures of insulin resistance [1,6].
However, the absence of a standardized clinical insulin
assay prevents establishment of a specific numerical cut-
point that can be of general use to identify insulin resis-
tant individuals [7]. Another approach is to use standard-
ized measurements of changes closely associated with
insulin resistance, and the characteristic dyslipidemia of
insulin resistant individuals, high triglyceride (TG) and low
high-density lipoprotein cholesterol (HDL-C) concentra-
tion, provided an attractive alternative [8]. The plasma
concentration ratio of TG/HDL-C is significantly correlated
with a direct measure of insulin-mediated glucose disposal
[6], and sex-specific cut-points have been shown to iden-
tify apparently healthy individuals (without diabetes or
CVD event) with cardio-metabolic risk profiles comparable
to what was seen when these individuals met the diag-
nostic criteria for the metabolic syndrome (MetS) [9e11].
Guerrero Romero et al. [12] have taken a somewhat
similar approach, using the fasting plasma TG and glucose
concentration to create a mathematical formula (TG  G
index) to serve as a surrogate estimate of insulin resis-
tance, and shown that this value is significantly correlated
with euglycemic clamp measurements of insulin action.
More recently, data have been published showing that the
TG/HDL-C ratio and the TG  G index are significantly
correlated to a similar degree with insulin-mediated
glucose disposal using the insulin suppression test [13].
Both of these approaches were initially evaluated
because of their relationship to insulin resistance, but their
ultimate clinical utility will depend upon their ability to
serve as simple clinical measures with which to identify
individuals at increased risk of diabetes, hypertension,
and/or incident CVD associated with insulin resistance
[2e5]. In that context, the TG/HDL-C ratio has previously
been shown to predict incident CVD in apparently healthy
persons [11]. More recently, Sánchez-Iñigo et al., have
shown that the TG  G index can predict incident ischemic
heart and peripheral artery disease [14]. Both approaches
seem comparable in terms of their simplicity to identify a
subset of individuals at significantly enhanced risk of
developing CVD. However, the fact that they are similarly
associated with a direct measure of insulin resistance [13]
does not mean that they would be equally effective in
predicting incident CVD. Thus, the current analysis was
initiated to address this issue by comparing the ability of
the TG  G index, the TG/HDL-C ratio and MetS criteria
[15] to predict CVD outcome in individuals without dia-
betes or previous CVD event.
Methods
Study population
In 2003, as part of a community intervention program
focused on cardio-metabolic risk factors, an epidemiolog-
ical study was conducted in Rauch city, Buenos Aires,Argentina (RAUCH project, phase 2). According to the last
national census available at the time of the survey, there
were 8246 individuals 15 years old in the urban area of
Rauch. The city lies in a rural area in the Centre-Southeast
region of the province of Buenos Aires and the population is
primarily of European origin. Blocks of the urban area of
Rauch city were randomly selected; because there were no
differences in socioeconomic factors or the number of in-
habitantswithin the city, a proportional probabilitywas not
taken into consideration. Previously trained, nurses from
Hospital Municipal of Rauch conducted the survey in the
subject’s place of residence. They went to the selected
homes (on up to 3 occasionswhen necessary tomeasure BP,
weight, and height and construct an epidemiological chart.
To minimize the chance of rejection, before the study a
diffusion campaign was performed that delivered written
information about the study to each selected residence.
Because the design was a prospective cohort study, the
sample size was determined taking into account the possi-
bility of losing track of subjects during the study. Twenty
percent of the inhabitants were regarded as a suitable and
affordable sample according to the economic resources
available. The surveywas performed from subjects between
15 and 80 years old who lived in chosen blocks (nZ 1308,
855women5117 years old and453men5216 years old,
P between sexesZ 0.63). Fifty-four subjects who had pre-
viously suffered CVD events were excluded. All measure-
ments necessary for the present studywere available in 926
individuals (622 women and 304 men).
In 2012, 796 individuals (86% of the baseline sample),
527 women and 269 men (or their relatives in case of
death), could be surveyed again to obtain information
concerning incident CVD events; the remaining in-
habitants (n Z 130) could not be found because they had
moved from Rauch city. As previously published [11], there
was no significant difference in the baseline characteristics
between subjects with and without follow-up period. In
order to avoid the effects of outliers, individuals with TG
concentration >500 mg/dL or a HDL-C concentration
>100 mg/dL were excluded [9e11]. Participants with a
history of diabetes or a fasting glucose concentration
126 mg/dL were also excluded. The remaining 723 in-
dividuals (486 women, and 237 men) were included in the
present analysis (Fig. 1).
Measurements
Clinical and biological variables were quantified as previ-
ously described [16]. In brief, weight was determined with
individuals wearing light clothes and no shoes. Height also
was measured without shoes, using a metallic metric tape;
waist circumference was measured with a relaxed
abdomen using a metallic metric tape on a horizontal
plane above the iliac crest; body mass index (BMI) was
calculated using the formula weight (kg)/height (m)2.
Concentrations of plasma glucose, TG, HDL-C, and fasting
plasma insulin were determined after an overnight (12-h)
fast. Low-density lipoprotein cholesterol (LDL-C) concen-
trations were estimated by the Friedewald formula [17].
Figure 1 Flow diagram of the study.
368 M.R. Salazar et al.Plasma for the insulin measurements was extracted by
centrifugation (15 min at 3000 r.p.m.) and frozen at 20 C
until assayed. Fasting plasma insulin concentrations were
determined using an immunoradiometric assay, with 2
monoclonal antibodies against 2 different epitopes of the
insulin molecule. The inter- and intra-assay coefficients of
variation were 8.0% and 3.8%, respectively, with the lowest
detectable level of 1.4 pmol/L. The homeostasis model
assessment of insulin resistance was calculated with the
formula ([Insulin (mU mL)  glucose (mmol/L)/22.5). The
TG-G index was calculated as the Ln [fasting TG (mg/
dL)  fasting glucose (mg/dL)/2] [12].
Assessment of endpoints
The first CVD event, including angina pectoris, myocardial
infarction, myocardial revascularization, and fatal or
nonfatal stroke was defined as the primary endpoint.
Structured interviewswere conductedwith each participant
by specially trained nurses and social workers. The collected
data were then evaluated by a highly qualified internist
(blinded with respect to the subject’s baseline CVD risk fac-
tors) to assign a specific outcome for every event. When
necessary, available medical records also were reviewed.
Definition of risk groups
Previously published cut points of TG/HDL-C concentration
ratios of 2.5 and 3.5 (mg/dL), for women and men,respectively, were used to classify participants as being
either at high or low cardiovascular disease risk [9]. These
cut points were created because they separated those
within the highest quartile of TG/HD-C ratios from the
remainder individuals. Consequently, the sample was also
divided into quartiles of TG  G index, and those in-
dividuals in the upper quartile of TG-G index also were
classified as being at high risk. Finally, the individuals were
also divided into those with the MetS (high risk) or
without the MetS (low risk), using the ‘‘harmonized’’
version of the MetS [15], in which three of the following
five criteria are required for diagnosis: (1) WC  102 cm in
men and 88 cm in women; (2) HDL-C < 40 mg/dL in men
and <50 mg/dL in women; (3) TG  150 mg/dL; (4)
SBP  130 mm Hg or DBP  85 mm Hg; or (5) fasting
plasma glucose  100 mg/dL.Statistical analyses
Continuous baseline variables (age, body mass index, WC,
SBP, DBP, glucose, cholesterol, LDL-C, HDL-C, TG, FPI and
HOMA-IR) were expressed as mean  standard deviation
(SD) and compared between risk categories using inde-
pendent samples ‘t’ test. Proportions (sex, current
smokers, drugs that patients take) were expressed as
percentages and compared by c2 test.
The relationship between TG/HDL-C ratio concentration
ratios and TG  G index as continuous variables was
evaluated using Pearson’s r coefficient and the agreement
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concordance (kappa, k). Receiver operating characteristic
(ROC) curves were constructed in order to provide a
graphic representation of the relationship between false-
positive (i.e. 1-specificity) and true-positive (sensitivity)
detection rates for both, TG  G and the TG/HDL-C ratio as
continuous variables. The area under the ROC curves and
95% confidence interval (95% CI) was used to compare the
two indices.
KaplaneMeier analysis was performed to estimate
mean survival time, and the equality of survival distribu-
tions for high vs. low risk based on use of the TG/HDL-C,
TG  G, or MetS criteria were tested with log rank (Man-
teleCox). The relative risks for CVD events between in-
dividuals above and below the TG/HDL-C sex-specific cut
points, in the top quartile of TG  G index values vs. the
remaining 3 quartiles, and with or without MetS were
estimated using three Cox proportional hazard models: (1)
unadjusted, (2) adjusted for age and sex, (3) adjusted for
sex, age, smoking, LDL-C, BMI, and aspirin, antihyperten-
sive and lipid-lowering drug use. The model-buildingTable 1 Demographic and metabolic characteristics of the study
population.
Women
(nZ 486)
Men
(nZ 237)
p
Age (yrs) 50  16 51  16 0.643
Current smokers (%) 19.8 28.8 0.005
Aspirin use (%) 2.1 3.4 0.205
Antihypertensive
drugs (%)
15.4 15.6 0.515
Lipid-lowering
drugs (%)
3.3 3.4 0.555
BMI (kg/m2) 25.1  4.5 26.4  3.7 <0.001
WC (cm) 91  12 96  12 <0.001
SBP (mmHg) 129  18 135  18 <0.001
DBP (mmHg) 80  11 84  12 <0.001
TG (mmol/L) 1.4  0.7 1.7  0.9 <0.001
Cholesterol (mmol/L) 5.9  1.3 5.9  1.2 0.527
LDL-C (mmol/L) 3.7  1.0 3.8  1.0 0.330
HDL-C (mmol/L) 1.6  0.3 1.4  0.3 <0.001
FPG (mmol/L) 5.2  0.7 5.4  0.7 <0.001
Continuous baseline variables were expressed as mean  standard
deviation and compared by independent samples ‘t’ test. Pro-
portions were expressed as percentages and compared by c2 test.
BMIZ body mass index, WCZwaist circumference; SBPZ systolic
blood pressure; DBPZ diastolic blood pressure; TGZ triglyceride;
LDL-CZ low density lipoprotein cholesterol; HDL-CZ high-density
lipoprotein cholesterol; FPGZ fasting plasma glucose; FPIZ fasting
plasma insulin; HOMA-IR Z homeostasis model assessment of in-
sulin resistance.
Table 2 Descriptive statistics of Triglyceride plasmatic levels (TG), H
Triglyceride-glucose Index (TG  G) and the Triglyceride/High-density Lip
Women (n Z 486)
Mean SD Median Ran
TG 124 63 106 35e
HDL-C 61 12 60 20e
TG/HDL-C ratio 2.2 1.5 1.8 0.5e
TG  G index 8.54 0.51 8.50 7.3eprocess took place in 3 blocks. In the first block, risk cat-
egories were included as categorical variables. In the sec-
ond block, sex and age were added. Finally, in the third
block conditional forward stepwise algorithm methods
were used for multivariable analysis and baseline (2003)
covariates were added; the probabilities for stepwise were
<0.05 and >0.10 for inclusion and exclusion, respectively.
The risk was expressed as hazard ratio (HR) and its 95%
confidence interval. Finally, a further analysis was per-
formed using both risk markers as continuous variables.
Since TG  G index is a log function, the TG/HDL-C ratio
was log transformed and both variables were included as
Z-scores.
All significant tests were 2-tailed, and p values < 0.05
were considered statistically significant. All statistical an-
alyses were performed using SPSS 18.0.
Results
Demographic, metabolic, and clinical characteristics of the
experimental population were previously published [16]
and are summarized in Table 1. Men were more often
current smokers, but there were no sex differences in
usage of aspirin or drugs to lower blood pressure of lipid
concentrations. Men were more obese, with higher values
for blood pressure and of TG and fasting glucose
concentrations.
Values of both risk markers, TG  G index and TG/HDL-
C ratio, were higher in men (Table 2). The cut-point for the
upper quartile of TG  G index was 8.98. The correlations
between the TG/HDL-C ratio and the TG  G index were
high in both men (0.84, p < 0.001) and women (0.80,
p < 0.001), and agreement between the 2 definitions to
identify individuals at high risk was highly statistically
significant (k Z 0.73, p < 0.001). Moreover, as shown in
Fig. 2, the area under the ROC curves was almost identical,
0.66 (95% CI Z 0.59e0.74, p < 0.001) for TG/HDL-C ratio
and 0.67 (95% CI Z 0.60e0.75, p < 0.001) for TG  G
index.
Table 3 compares the cardio-metabolic risk profile of
individuals identified as being at high risk on the basis of
each of the 3 indices and it can be seen that somewhat
fewer participants were defined as high risk by the TG  G
index. Since substantial numbers of individuals meet
criteria for low or high risk concordantly on the basis of all
3 indices, statistical comparison of individual cardio-
metabolic risk factors based on the index used for pur-
pose of classification is not appropriate. On the other hand,
visual comparison of the data in Table 3 suggests that theigh-density Lipoprotein Cholesterol plasmatic levels (HDL-C), the
oprotein Cholesterol Ratio (TG/HDL-C) according sex.
Men (n Z 237)
ge Mean SD Median Range
398 151 80 131 44e491
99 54 15 53 27e85
14.6 3.0 2.0 2.6 0.6e13.6
9.9 8.77 0.55 8.76 7.6e10.0
Figure 2 Receiver operating characteristic curves of the triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio and the plasma
triglyceride  glucose (TG  G) index for prediction of insulin resistance.
Table 3 Comparison of the cardio-metabolic risk profile in individuals identified as high risk vs. low risk by the Triglyceride-glucose Index
(TG  G), the Triglyceride/High-density Lipoprotein Cholesterol Ratio (TG/HDL-C) and Metabolic Syndrome Diagnosis (MetS).
TG  G index TG/HDL-C ratio MetS
Low nZ 542
(75.0%)
High n Z 181
(25.0%)
Low nZ 517
(71.5%)
High n Z 206
(28,5%)
No nZ 497
(68.7%)
Yes n Z 226
(31.3%)
Age (yrs) 49  16 54  14 <0.001 49  17 53  14 0.002 47  16 58  12 <0.001
Women (%) 72.1 51.9 <0.001 68.3 64.6 0.191 66.6 68.6 0.609
Current smokers (%) 22.7 22.8 0.991 20.2 29.3 0.008 22.4 23.6 0.727
Aspirin use (%) 2.6 2.2 0.780 2.7 1.9 0.551 2.2 3.1 0.479
Antihypertensive (%) 14.2 19.3 0.099 13.0 21.8 0.003 9.7 18.3 <0.001
Lipid-lowering (%) 3.1 3.9 0.635 3.1 3.9 0.593 2.2 5.8 0.014
BMI (kg/m2) 24.8  4.1 27.8  3.9 <0.001 24.9  4.2 27.2  4.0 <0.001 24.1  3.7 28.6  3.9 <0.001
WC (cm) 91  13 98  10 <0.001 91  13 96  9 <0.001 89  11 100  12 <0.001
SBP (mmHg) 129  17 137  18 <0.001 128  17 137  18 <0.001 126  16 142  16 <0.001
DBP (mmHg) 80  11 85  11 <0.001 80  11 84  11 <0.001 78  10 88  10 <0.001
TG (mmol/L) 1.1  0.4 2.6  0.7 <0.001 1.1  0.4 2.4  0.8 <0.001 1.2  0.6 2.1  0.9 <0.001
Cholesterol (mmol/L) 5.7  1.1 6.6  1.3 <0.001 5.7  1.2 6.4  1.2 <0.001 5.7  1.2 6.4  1.2 <0.001
LDL-C (mmol/L) 3.6  1.0 4.1  1.2 <0.001 3.6  1.0 4.0  1.1 <0.001 3.6  1.0 4.0  1.1 <0.001
HDL-C (mmol/L) 1.6  0.3 1.4  0.3 <0.001 1.6  0.3 1.3  0.3 <0.001 1.6  0.3 1.4  0.3 <0.001
Glucose (mmol/L) 5.1  0.7 5.7  0.7 <0.001 5.2  0.7 5.5  0.7 <0.001 5.1  0.6 5.7  0.6 <0.001
FPI (Pmol/L) 48  23 65  46 <0.001 47  23 64  44 <0.001 46  23 64  41 <0.001
HOMA-IR 1.5  1.0 2.2  1.7 <0.001 1.5  1.0 2.1  1.6 <0.001 1.5  1.0 2.1  1.5 <0.001
Continuous baseline variables were expressed as mean  standard deviation and compared by independent samples ‘t’ test. Proportions were
expressed as percentages and compared by c2 test. BMI Z body mass index, WC Z waist circumference; SBP Z systolic blood pressure;
DBPZ diastolic blood pressure; TGZ triglyceride; LDL-CZ low density lipoprotein cholesterol; HDL-CZ high-density lipoprotein cholesterol;
FPG Z fasting plasma glucose; FPI Z fasting plasma insulin; HOMA-IR Z homeostasis model assessment of insulin resistance.
370 M.R. Salazar et al.cardio-metabolic profiles of the three different groups
were relatively comparable, with relatively minor differ-
ences related to the components of the index used. It is
noteworthy that TG/HDL-C ratio and MetS identified as
high risk a similar proportion of men and women but the
TG  G index identified significantly more men
(p < 0.001).In the follow-up period (5781 subjects-year, mean
8.16  1.3 years), there were 42 CVD events: 24 nonfatal
coronary events (14 angina pectoris, 6 myocardial infarc-
tion, and 4 myocardial revascularization), 8 fatal coronary
events (4 myocardial infarction, 2 unspecific coronary
heart disease, and 2 sudden death), 7 nonfatal strokes, and
3 fatal strokes. There also were 30 non-cardiovascular
Estimates of insulin resistance and cardiovascular disease 371deaths. CVD events were documented in approximately
more than twice as many subjects classified at high risk by
both, baseline TG/HDL-C ratios (12.2 vs. 5.3% subjects/10
years, p Z 0.005) or TG  G index (13.4 vs. 5.3% subjects/
10 years, p Z 0.002). These results resembled those using
MetS criteria (13.4% vs. 4.5% of subjects/10 years,
p < 0.001).
Table 4 shows the HR of developing CVD. These results
show that both unadjusted and adjusted for age and sex
ratios were significantly increased in individuals at high
risk as defined by their TG  G Index, TG/HDL-C ratio, or
MetS diagnosis. Furthermore, age and sex adjusted HR
were comparable when individuals were identified with
all three of the indices.
Furthermore, when analyzed as continuous variables
both, TG  G index and TG/HDL-C ratio predicted a similar
augmentation of risk (Table 5). However, after adjustment
for BMI, LDL-C, smoking and use of aspirin, antihyperten-
sive and lipid-lowering drugs, persons classified on the
basis of the TG/HDL-C ratio or the MetS maintain their
statistical significance HRs, but the HR of CVD was only of a
marginal statistical significance (p Z 0.087) in persons
identified the TG  G index (Table 4).
Figure 3 shows free events cumulative survival,
adjusted by sex, age and covariates, in individuals classi-
fied as high versus low risk using the TG/HDL-C ratio (a),
the upper quartile of TG  G index (b) and MetS diagnostic
criteria (c).
Discussion
Despite the similarities between the three approaches to
identify insulin resistance and enhanced cardio-metabolic
risk, the TG  G index seems to be somewhat lessTable 4 Hazard Ratios (HR) of cardiovascular events occurring in individu
Plasma Triglyceride/High-density Lipoprotein Cholesterol Ratio (TG/HDL-C
Crude incidence
100 subjects/10 years
Cox models
Unadjusted Ad
HR 95% CI p HR
TG/HDL-C ratio low 5.3 (n Z 517)
high 12.2 (n Z 206)
2.34 1.28e4.29 0.006 2.1
TG  G Index low 5.3 (n Z 542)
high 13.4 (n Z 181)
2.58 1.40e4.73 0.002 1.9
MetS no 4.5 (nZ 497)
yes 13.4 (n Z 226)
3.02 1.64e5.54 <0.001 1.9
a BMI, LDL-cholesterol, smoking, aspirin, antihypertensive and lipid-low
Table 5 Hazard Ratios (HR) of cardiovascular events occurring accordin
Lipoprotein Cholesterol Ratio (TG/HDL-C) analyzed as continuous variable
Cox Models
Unadjusted Adjusted for sex
HR 95% CI p HR 95% C
TG/HDL-C ratio 1.64 1.24e2.17 <0.001 1.55 1.15e
TG  G index 1.76 1.31e2.35 <0.001 1.54 1.12e
a BMI, LDL-cholesterol, smoking, aspirin, antihypertensive and lipid-lowsuccessful than either the TG/HDL-C ratio or the MetS in
predicting incident CVD. The relative similarity in the
increased risk when both indices are analyzed as contin-
uous variables does not diminish the need to have specific
cutoff values to use in clinical for application in clinical
practice. When adjusted for relevant covariates, e.g., age,
sex, BMI. LDL-cholesterol, smoking, and use of aspirin and
blood pressure or lipid lowering drugs (Table 4), the haz-
ard ratio for incident CVD remained statistically significant
when evaluated by the TG/HDL-C ratio (p Z 0.021) or the
MetS criteria p Z 0.036), but not by the TG  G index
(p Z 0.087).
In view of the many similarities that have been shown
to exist between the TG  G index and the TG/HDL-C ratio,
it was surprising that, after the adjustment for covariates,
the TG  G index was less successful in identifying inci-
dent CVD in individuals without diabetes. We can only
speculate as why the current analysis found the TG  G
index to be a less robust predictor of incident CVD than
described by Sánchez-Íñigo et al. [14]. The experimental
population in their study seems similar to the current one
in terms age, race/ethnicity, and duration of follow-up.
Furthermore, using the same cut-point (8.43) to define
the upper quartile of the TG  G index as proposed by
Sánchez-Íñigo et al. [14] did not substantially change the
hazard ratio. However, there are two important differences
between the studies. Firstly, Sánchez-Íñigo et al. [14]
included patients with diabetes, whereas they were
excluded from this analysis. Inclusion of subjects with
diabetes would have two effects; 1) increasing the TG  G
index to a degree not attainable when patients with dia-
betes are excluded from the population; and 2) increasing
CVD as a consequence of the multiple risk factors present
in patients with manifest diabetes. These two effects,als defined as high risk using Triglyceride-glucose Index (TG  G), the
) and the Metabolic Syndrome Diagnosis (MetS).
justed for sex and age Adjusted for sex, age, and covariatesa
95% CI p HR 95% CI p
9 1.19e4.02 0.012 2.06 1.12e3.80 0.021
2 1.04e3.59 0.036 1.72 0.93e3.19 0.087
3 1.04e3.58 0.036 1.93 1.04e3.58 0.036
ering drug use.
g Triglyceride-glucose Index (TG  G) and Triglyceride/High-density
s.
and age Adjusted for sex, age, and covariatesa
I p HR 95% CI p
2.09 0.004 1.53 1.11e2.11 0.010
2.12 0.009 1.46 1.03e2.08 0.033
ering drug use.
Figure 3 Free events cumulative survival, adjusted by sex, age, LDL-C levels, BMI, smoking, and use of antihypertensive, lipid-lowering drugs and
aspirin, in individuals classified as high versus low risk using the plasma triglyceride/high density-lipoprotein cholesterol ratio (TG/HDL-C) (a), the
plasma triglyceride  glucose index (TG  G) (b) and metabolic syndrome (MetS) diagnostic criteria (c).
372 M.R. Salazar et al.acting in concert, could help explain why Sánchez-
Íñigo et al. [14] were able to show that the TG  G index
predicted incident CVD when patients with diabetes were
included in the experimental population, whereas their
absence may account for the failure to discern a compa-
rable degree of predictability in the current study.
Furthermore, the observations by Steele et al. [18]., Faerch
et al. [19] and the data of the Emerging Risk Factors
Collaboration [20] suggest that, in the absence of diabetes,
mild elevation of fasting plasma glucose, per se, has rela-
tively little adverse effect on macrovascular disease. Sup-
porting this notion, our working group, in a recently
published study, shows that the risk to develop CVD
events is accentuated in individuals with prediabetes
mellitus who are also insulin resistant [21].
Secondly, the same proportion of women and menwere
identified as high risk using the TG/HDL-C ratio and MetS
diagnosis, whereas the TG  G index identified more men
than women. An increase in proportion of men at high risk
for CVD was also true of the report by Sánchez-Íñigo et al.
[14], suggesting the potential importance of sex differ-
ences, and the need to take sex-specific effects into ac-
count as is done when using the TG/HDL-C ratio or the
MetS diagnostic criteria.
Although the analysis and the results appear straight-
forward, there are some major concerns that must beemphasized. In the first place, the CVD events were
recorded based in a structured interview. Subsequently,
the collected data were evaluated by a qualified internist
(blinded with respect to the subject’s baseline CVD risk
factors) to assign a specific outcome for every event. Also,
when necessary, available medical records were reviewed.
Secondly, since the population was quite homogeneous,
the findings might not apply to ethnic/racial groups that
are not primarily of European descent. Finally, there were a
relatively small number of documented CVD events and
the adjusted HR of incident CVD using the TG  G index
was of borderline significance, it is possible that a larger
sample size could lead to a different result. On the other
hand, the number of CVD events was sufficient to docu-
ment statistically significant relationships between high
CVD risk and increased CVD events when persons were
classified by either the TG/HDL-C ratio of the MetS criteria.
Although far from definitive, our results suggest that
the apparent similarity of the TG  G index and the TG/
HDL-C ratio to identify apparently healthy persons who
are insulin resistant [12,13] does not mean that the 2
indices have the same ability to predict CVD events in p.
Thus, despite the limitations of the current analysis out-
lined above, the fact that increased CVD was seen in high
risk persons identified by either the TG/HDL-C ratio or the
MetS diagnostic criteria raises questions as to the ability of
Estimates of insulin resistance and cardiovascular disease 373the TG  G index to accomplish the same task. The ulti-
mate decision as to the clinical utility of the TG  G index
will depend upon results of similar analyses by in-
vestigators with larger data bases.
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